Lacutamab
Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma[1].
Product Specifications
CAS Number
2187368-16-5
Product Name Alternative
IPH 4102; Anti-KIR3DL2/CD158k Reference Antibody (lacutamab)
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lacutamab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Lacutamab]
Molecular Weight
(144.52 kDa)
References & Citations
[1]Van Der Weyden C, et, al. IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2018 Aug;27 (8) :691-697.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YP-W21518-01 48 Tests
Mouse squamous cell carcinoma antigen (SCC-Ag) ELISA Kit
Sign In for Pricing
View Details YP-W21518-02 96 Tests
Mouse squamous cell carcinoma antigen (SCC-Ag) ELISA Kit
Sign In for Pricing
View Details